Internalization of targeted quantum dots by brain capillary endothelial cells in vivo
Authors:
Open Access
- 6 October 2015
- journal article
- research article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 36 (4) , 731-742
Abstract
Receptors located on brain capillary endothelial cells forming the blood–brain barrier are the target of most brain drug delivery approaches. Yet, direct subcellular evidence of vectorized transport of nanoformulations into the brain is lacking. To resolve this question, quantum dots were conjugated to monoclonal antibodies (Ri7) targeting the murine transferrin receptor. Specific transferrin receptor-mediated endocytosis of Ri7-quantum dots was first confirmed in N2A and bEnd5 cells. After intravenous injection in mice, Ri7-quantum dots exhibited a fourfold higher volume of distribution in brain tissues, compared to controls. Immunofluorescence analysis showed that Ri7-quantum dots were sequestered throughout the cerebral vasculature 30 min, 1 h, and 4 h post injection, with a decline of signal intensity after 24 h. Transmission electron microscopic studies confirmed that Ri7-quantum dots were massively internalized by brain capillary endothelial cells, averaging 37 ± 4 Ri7-quantum dots/cell 1 h after injection. Most quantum dots within brain capillary endothelial cells were observed in small vesicles (58%), with a smaller proportion detected in tubular structures or in multivesicular bodies. Parenchymal penetration of Ri7-quantum dots was extremely low and comparable to control IgG. Our results show that systemically administered Ri7-quantum dots complexes undergo extensive endocytosis by brain capillary endothelial cells and open the door for novel therapeutic approaches based on brain endothelial cell drug delivery.Keywords
This publication has 40 references indexed in Scilit:
- Bispecific antibodies for delivery into the brainCurrent Opinion in Chemical Biology, 2013
- Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptorProceedings of the National Academy of Sciences, 2013
- Efficient In Vivo Delivery of siRNA Into Brain Capillary Endothelial Cells Along With Endogenous LipoproteinMolecular Therapy, 2011
- In Vivo Labeling of Brain Capillary Endothelial Cells after Intravenous Injection of Monoclonal Antibodies Targeting the Transferrin ReceptorMolecular Pharmacology, 2011
- siRNA nanocarriers based on methacrylic acid copolymersJournal of Controlled Release, 2011
- Targeting the insulin receptor: nanoparticles for drug delivery across the blood–brain barrier (BBB)Journal of Drug Targeting, 2010
- Distribution and ultrastructural features of the serotonin innervation in rat and squirrel monkey subthalamic nucleusEuropean Journal of Neuroscience, 2010
- Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseasesNeurobiology of Disease, 2010
- Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood–brain barrier (BBB)European Journal of Pharmaceutics and Biopharmaceutics, 2009
- The blood-brain barrierExperimental Eye Research, 1977